Education
About Us
Working with TipRanks
Follow Us
Myomo Inc (MYO)
:MYO
MYO Stock Chart & Stats
$1.12
-$0.13(-1.86%)
At close: 4:00 PM EST
$1.12
-$0.13(-1.86%)
Day’s Range― - ―
52-Week Range$0.80 - $7.17
Previous CloseN/A
Volume192.17K
Average Volume (3M)2.26M
Market Cap
$41.20M
Enterprise Value$86.77M
Total Cash (Recent Filing)$15.48M
Total Debt (Recent Filing)$12.43M
Price to Earnings (P/E)―
Beta1.84
Next Earnings
Nov 05, 2025EPS Estimate
-0.11Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.11
Shares Outstanding37,801,070
10 Day Avg. Volume2,169,943
30 Day Avg. Volume2,263,738
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap2.11
Enterprise Value/Revenue2.13
Enterprise Value/Gross Profit3.07
Enterprise Value/Ebitda-10.39
Forecast
1Y Price Target
$6.50Price Target Upside480.36% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
Bulls Say, Bears Say
Bulls Say
Growth PotentialThe company's approach to its direct billing segment and growth potential in the orthotic and prosthetic and international segments is promising.
Market PositionThe MyoPro product is well-positioned to address a largely untapped market for individuals with upper-arm paralysis.
Product DevelopmentThe launch of improved products and development of new sales channels highlight the company's commitment to reinforcing its market position.
Bears Say
Gross MarginThe company's gross margin dropped to 63% from 67% due to higher material and overhead spending and lower volume.
Revenue GuidanceLower-than-expected 3Q25 revenue guidance and reduced full-year 2025 guidance highlight challenges with lead quality and slower authorizations.
Revenue ImpactThe number of patients added to Myomo's pipeline was significantly lower than expected, impacting the company’s revenues.
Myomo News
MYO FAQ
What was Myomo Inc’s price range in the past 12 months?
Myomo Inc lowest stock price was $0.80 and its highest was $7.17 in the past 12 months.
What is Myomo Inc’s market cap?
Myomo Inc’s market cap is $41.20M.
When is Myomo Inc’s upcoming earnings report date?
Myomo Inc’s upcoming earnings report date is Nov 05, 2025 which is in 12 days.
How were Myomo Inc’s earnings last quarter?
Myomo Inc released its earnings results on Aug 11, 2025. The company reported -$0.11 earnings per share for the quarter, missing the consensus estimate of -$0.106 by -$0.004.
Is Myomo Inc overvalued?
According to Wall Street analysts Myomo Inc’s price is currently Undervalued.
Does Myomo Inc pay dividends?
Myomo Inc does not currently pay dividends.
What is Myomo Inc’s EPS estimate?
Myomo Inc’s EPS estimate is -0.11.
How many shares outstanding does Myomo Inc have?
Myomo Inc has 37,801,070 shares outstanding.
What happened to Myomo Inc’s price movement after its last earnings report?
Myomo Inc reported an EPS of -$0.11 in its last earnings report, missing expectations of -$0.106. Following the earnings report the stock price went down -38.636%.
Which hedge fund is a major shareholder of Myomo Inc?
Currently, no hedge funds are holding shares in MYO
Myomo Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$6.50 (480.36% Upside)
$6.50 (480.36% Upside)
Blogger Sentiment
Neutral
MYO Sentiment 50%
Sector Average 68%
Sector Average 68%
Insider Transactions
Bought Shares
Worth $159.5K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 0.7%
Last 30 Days ▲ 22.4%
Last 30 Days ▲ 22.4%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-72.00%
12-Months-Change
Fundamentals
Return on Equity
-68.32%
Trailing 12-Months
Asset Growth
138.86%
Trailing 12-Months
Company Description
Myomo Inc
Myomo, Inc. is a medical technology company that specializes in developing wearable robotic devices designed to restore mobility for individuals with upper limb disabilities. The company primarily operates in the healthcare sector, focusing on rehabilitation and assistive technologies. Myomo's core products include myoelectric orthoses that enable users to control their arm and hand movements through muscle signals, enhancing their ability to perform daily activities and improving their quality of life.
MYO Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted strong revenue growth and international expansion, particularly in Germany, and a record number of pipeline additions. However, the company faced challenges with lead quality and conversion, increased operating expenses, and a decrease in Medicare Advantage revenue. Myomo is making strategic adjustments to address these issues, including cost-cutting measures and shifts in advertising strategy.View all MYO earnings summariesMYO Stock 12 Month Forecast
Average Price Target
$6.50
▲(480.36% Upside)
Technical Analysis
Electrocore
―
Modular Medical
―
Vicarious Surgical
―
Adagio Medical Holdings
―
Inspira Technologies Oxy BHN
―
Ownership Overview
17.17% Insiders
6.09% Mutual Funds
0.44% Other Institutional Investors
69.47% Public Companies and
Individual Investors